Elekta AB (publ) (EKTAY) Projected to Post Earnings on Thursday

Elekta AB (publ) (OTCMKTS:EKTAY) is anticipated to release its earnings data on Thursday, March 6th. Analysts expect Elekta AB (publ) to post earnings of $0.09 per share and revenue of $444.70 million for the quarter.

Elekta AB (publ) (OTCMKTS:EKTAY) last issued its quarterly earnings data on Friday, February 21st. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01). The company had revenue of $416.86 million for the quarter, compared to analyst estimates of $435.89 million. Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. On average, analysts expect Elekta AB (publ) to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Elekta AB (publ) Trading Down 0.4 %

Shares of Elekta AB (publ) stock opened at $5.64 on Thursday. The stock has a market cap of $2.16 billion, a PE ratio of 22.56 and a beta of 1.22. Elekta AB has a 52-week low of $5.25 and a 52-week high of $8.24. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.81 and a current ratio of 1.05. The firm has a 50-day moving average of $5.72 and a 200-day moving average of $6.08.

Elekta AB (publ) Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, March 27th. Shareholders of record on Friday, March 7th will be paid a dividend of $0.1072 per share. The ex-dividend date of this dividend is Friday, March 7th. Elekta AB (publ)’s payout ratio is 40.00%.

Wall Street Analysts Forecast Growth

Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a report on Wednesday, January 29th.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.